The Canadian Generic Pharmaceutical Association

The CGPA represents a dynamic group of companies who specialize in the production of high quality, affordable generic prescription medicines and active pharmaceutical ingredients. Our members and the 11,000 Canadians who work in our industry play a vital role in the economy and support a sustainable health-care system by providing Canadians with safe, effective, affordable prescription medicines.

News

Toronto, November 14, 2017 – Brand-name drug companies’ research and development spending as a percentage of sales in Canada is less than half of the 10% the industry committed to when their periods of market exclusivity were increased in 1987, according to the most recent annual report from the federal government’s Patented Medicine Prices Review Board (PMPRB). Read More